American Journal of Clinical Nutrition, Vol 37, 641-644, Copyright © 1983 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Vitamin E in plasma and platelets of human diabetic patients and control subjects

GT Vatassery, JE Morley and MA Kuskowski

Vitamin E concentrations were determined in plasma and platelet samples from 23 diabetic and 30 control human subjects. The mean concentrations of alpha and total tocopherols in the plasma and platelets of the diabetics were higher than that of the controls. The mean gamma tocopherol concentrations in both plasma and platelets were similar in diabetics and controls. The platelet vitamin E concentrations decreased significantly with age in only the controls and not in the diabetics. Thus diabetics have higher concentrations of tocopherols in blood platelets and plasma. The total plasma tocopherol concentrations correlated significantly with total plasma cholesterol, triglyceride, and total lipid concentrations in both diabetic and control groups. However, no significant correlations were observed between platelet tocopherol levels and plasma lipids in either group. In five subjects plasma and platelet vitamin E concentrations remained unchanged during standard glucose tolerance tests.

This article has been cited by other articles:

				S. Liu, I-M. Lee, Y. Song, M. Van Denburgh, N. R. Cook, J. E. Manson, and J. E. Buring Vitamin E and Risk of Type 2 Diabetes in the Women's Health Study Randomized Controlled Trial. Diabetes, October 1, 2006; 55(10): 2856 - 2862. [Abstract] [Full Text] [PDF]

				S. Czernichow, A. Couthouis, S. Bertrais, A.-C. Vergnaud, L. Dauchet, P. Galan, and S. Hercberg Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations. Am. J. Clinical Nutrition, August 1, 2006; 84(2): 395 - 399. [Abstract] [Full Text] [PDF]

				J. Montonen, P. Knekt, R. Jarvinen, and A. Reunanen Dietary Antioxidant Intake and Risk of Type 2 Diabetes Diabetes Care, February 1, 2004; 27(2): 362 - 366. [Abstract] [Full Text] [PDF]

				C. M. Palmeira, D. L. Santos, R. Seica, A. J. Moreno, and M. S. Santos Enhanced mitochondrial testicular antioxidant capacity in Goto-Kakizaki diabetic rats: role of coenzyme Q Am J Physiol Cell Physiol, September 1, 2001; 281(3): C1023 - C1028. [Abstract] [Full Text] [PDF]

				B. Manuel y Keenoy, H. Shen, W. Engelen, J. Vertommen, G. Van Dessel, and A. Lagrou Long-Term Pharmacologic Doses of Vitamin E Only Moderately Affect the Erythrocytes of Patients with Type 1 Diabetes Mellitus J. Nutr., June 1, 2001; 131(6): 1723 - 1730. [Abstract] [Full Text]

				K. J. Helzlsouer, H.-Y. Huang, A. J. Alberg, S. Hoffman, A. Burke, E. P. Norkus, J. S. Morris, and G. W. Comstock Association Between {{alpha}}-Tocopherol, {{gamma}}-Tocopherol, Selenium, and Subsequent Prostate Cancer J Natl Cancer Inst, December 20, 2000; 92(24): 2018 - 2023. [Abstract] [Full Text] [PDF]

				W. Engelen, B. M. y Keenoy, J. Vertommen, and I. De Leeuw Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type 1 diabetes Am. J. Clinical Nutrition, November 1, 2000; 72(5): 1142 - 1149. [Abstract] [Full Text] [PDF]